Naoto Kubota

Also affiliated with Tochigi Cancer Center, The University of Texas Southwestern Medical Center, Kumamoto University

Immunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyEngineeringMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “A Therapeutically Targetable TAZ-TEAD2 Pathway Drives the Growth of Hepatocellular Carcinoma via ANLN and KIF23”.

A Therapeutically Targetable TAZ-TEAD2 Pathway Drives the Growth of Hepatocellular Carcinoma via ANLN and KIF23

Gastroenterology(2023)10.1053/j.gastro.2023.02.043

N/A

0.639DataRank · unranked

70 citations

Dingzi Yin, Naoto Kubota, Xiaobo Wang, Aveline Filliol, Helen Remotti +7 more

Epidermal Growth Factor Receptor Inhibition With Erlotinib in Liver: Dose De-Escalation Pilot Trial as an Initial Step in a Chemoprevention Strategy

Gastro Hep Advances(2024)10.1016/j.gastha.2024.01.009

N/A

0.365DataRank · unranked

6 citations

David M. Zahrieh, Carrie Strand, Yujin Hoshida, Thomas J. Flotte, Gary Della’Zanna +9 more

Transcriptome-Guided Design of Physiological Multilineage Liver Organoids

Trends in Genetics(2021)10.1016/j.tig.2021.01.007

N/A

0DataRank · unranked

1 citations

Naoto Kubota, Yujin Hoshida, Shijia Zhu

Liver cancer risk-predictive molecular biomarkers specific to clinico-epidemiological contexts

Advances in cancer research(2022)10.1016/bs.acr.2022.01.005

N/A

0DataRank · unranked

2 citations

Naoto Fujiwara, Yujin Hoshida, Naoto Kubota

Clinical and Molecular Prediction of Hepatocellular Carcinoma Risk

Journal of Clinical Medicine(2020)10.3390/jcm9123843

N/A

0DataRank · unranked

18 citations

Naoto Fujiwara, Yujin Hoshida, Naoto Kubota

Disseminative Recurrence Signature for Hepatocellular Carcinoma From Nonalcoholic Fatty Liver Disease

Gastro Hep Advances(2023)10.1016/j.gastha.2023.03.021

N/A

0DataRank · unranked

6 citations

Naoto Kubota, Shijia Zhu, Shigeki Nakagawa, Hideo Baba, Yujin Hoshida +1 more

Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.20.533505

N/A

0DataRank · unranked

10 citations

Shijia Zhu, Yuemeng Jia, Yunguan Wang, Naoto Kubota, Naoto Fujiwara +14 more

Data from Activating an Adaptive Immune Response with a Telomerase-Mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma

(2023)10.1158/1535-7163.c.6653595.v2

N/A

0DataRank · unranked

0 citations

Silvia Siteni, Summer Barron, Ann Marie Flusché, Naoto Kubota, Chunhua Yu +12 more

The Spatial Extracellular Proteomic Tumor Microenvironment Distinguishes Molecular Subtypes of Hepatocellular Carcinoma

Journal of Proteome Research(2024)10.1021/acs.jproteome.4c00099

N/A

0DataRank · unranked

7 citations

Harrison Taylor, Mengjun Wang, Andrew DelaCourt, Christin Edge, David Lewin +16 more

Activating an Adaptive Immune Response with a Telomerase-Mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0039

N/A

0DataRank · unranked

14 citations

Silvia Siteni, Summer Barron, Ann Marie Flusché, Naoto Kubota, Chunhua Yu +12 more

Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development

Gastroenterology(2021)10.1053/j.gastro.2021.12.250

N/A

0DataRank · unranked

40 citations

Naoto Fujiwara, Bhuvaneswari Koneru, Atsushi Ono, Naoto Kubota, Arun Kumar Jajoriya +54 more